Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is focusing on brand strength and long-term growth potential, with a shift in expenditure from traffic costs to brand-building efforts [6] - The company is accelerating its offline national expansion and expects continued recovery in e-commerce, supported by a proactive management team [6] - The company has effectively responded to public sentiment issues and is on a path to operational recovery [6] Financial Data and Profit Forecast - Total revenue is projected to grow from 3,254 million in 2024 to 7,145 million by 2027, with a compound annual growth rate (CAGR) of approximately 28% [5] - Net profit attributable to the parent company is expected to increase from 288 million in 2024 to 709 million by 2027, reflecting a CAGR of around 31.9% [5] - Earnings per share (EPS) is forecasted to rise from 0.67 in 2024 to 1.65 by 2027 [5] - The company maintains a gross margin of around 53% to 54% over the forecast period [5] Market Expansion and E-commerce Recovery - The company is expanding into peripheral markets such as Guangdong, Hunan, Hubei, Jiangsu, and Hebei, leveraging its probiotic product offerings [6] - E-commerce platforms like Douyin and Tmall are expected to contribute significantly to revenue growth, with a focus on brand promotion and consumer trust recovery [6] - The company has implemented measures to enhance waste management and prevent the illegal recycling of defective products, demonstrating a commitment to consumer protection [9]
百亚股份(003006):注重品牌力沉淀,看好中长期成长性